Capnography During Percutaneous Transhepatic Cholangiodrainage (PTCD) (HepaBreath)

Capnography provides noninvasive monitoring of ventilation and can allow early recognition of altered respiration patterns and apnea. The aim of this prospective study was to compare the detection of apnea and the prediction of oxygen desaturation and hypoxemia by capnography versus clinical surveillance during procedural sedation for percutaneous transhepatic cholangiodrainage (PTCD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Apnea Complications Hypoxemia Hypoxia Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Klinikum rechts der Isar

Munich, Bavaria, 81675, Germany

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age>=18
Scheduled for PTCD with midazolam and propofol sedation

Exclusion criteria

age less than 18 years
ASA class V
allergy to narcotic drugs
pregnancy
pre-existing hypotension, bradycardia or hypoxemia

Treatment and study plan

Capnography

Procedure

Primary outcomes

mean cumulative duration of detected apnea episodes per patient (capnographic vs. clinical surveillance)

Secondary outcomes

overall number of detected episodes of apnea
the occurrences of oxygen desaturation and hypoxemia

Sponsors and collaborators

Lead sponsor

Technical University of Munich

Other

Registry information

Important dates

Study start: 2010
Primary completion: 2011
Study completion: 2011
First posted: Apr 30, 2012
Registry last updated: Apr 30, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed